Clinical efficacy of JAK inhibitors for RA patients with poor-prognosis factors: the ANSWER cohort study. - Nozaki Y; Murata K; Onishi A; Tsujimoto K; Yamamoto W; Yamada H; Sendo S; Hashimoto M; Okano T; Shiba H; Hiramatsu Y; Son Y; et al. (Rheumatology (Oxford, England), 2026)